ADMA
ADMA Biologics Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -248.6% | -214.8% | -171.4% | -163.8% | -369.0% | -259.6% | -241.6% | -138.8% | -38.6% | 3.4% | 27.8% | 9.9% | |
| 4.2% | 6.5% | 4.4% | 11.8% | 20.3% | 11.1% | 9.3% | 6.8% | 4.6% | 3.2% | 1.9% | 1.6% | |
| 21.1% | 23.8% | 11.7% | 6.9% | 13.1% | 9.0% | 6.8% | 4.3% | 3.4% | 2.4% | 3.2% | 3.9% | |
| 25.3% | 34.6% | 11.7% | 10.6% | 13.8% | 9.7% | 4.3% | 4.6% | 9.9% | – | – | – | |
| 3.0% | -9.4% | -9.5% | -1.2% | -21.7% | -114.2% | -80.0% | -63.8% | -11.9% | -3.9% | -4.3% | -27.4% | |
| 39.3% | 0.4% | 0.7% | 11.8% | 12.3% | 13.0% | 30.1% | 16.7% | 9.0% | 1.9% | 2.0% | 4.4% | |
| -68.3% | -24.3% | 8.5% | 66.8% | -12.3% | -13.0% | -30.1% | -16.7% | -9.0% | -1.9% | -2.0% | -4.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.1% | 1.9% | – | – | – | |
| -0.2% | 143.6% | 121.0% | 172.3% | 252.9% | 165.2% | 310.8% | -0.1% | -1.9% | -0.5% | – | -6.3% | |
| 165.8% | -216.5% | -0.6% | 102.5% | -0.2% | 116.8% | 32.0% | 0.0% | 31.8% | -9.1% | -14.1% | -0.2% | |
| 165.6% | 144.9% | 157.9% | 266.9% | 252.7% | 272.6% | 340.8% | 149.5% | 70.6% | -15.1% | -13.7% | -8.6% | |
| -151.3% | -94.2% | -4.9% | 170.0% | -128.7% | 0.0% | 69.1% | -6.0% | 23.0% | -13.6% | 12.1% | -3.0% | |
| -287.9% | -215.2% | -172.1% | -175.5% | -381.4% | -272.6% | -271.7% | -155.5% | -47.7% | 1.5% | 25.8% | 5.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.